AUDREY RYAN: Open Payments
NPI 1154052777 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,567 in 73 payments from 20 companies in 2025. Trend: 2023 $17 · 2024 $1,334 · 2025 $1,567
Food & beverage: $1,567
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $215 |
| Novo Nordisk Inc | 11 | $183 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $153 |
| ABBVIE INC. | 6 | $136 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| ALK-Abello, Inc | 5 | $107 |
| Exact Sciences Corporation | 5 | $88 |
| Axsome Therapeutics, Inc. | 3 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $73 |
| Lilly USA, LLC | 4 | $73 |
Products named: AIRSUPRA, XIFAXAN, REXULTI, Odactra, VRAYLAR, FREESTYLE LIBRE 3, JARDIANCE, Ozempic.
Industry payments across NY — which companies pay providers there.
